UBS Group’s Moringa Acquisition Corp Class A Ordinary Shares MACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-45
Closed -$453 10734
2022
Q4
$453 Hold
45
﹤0.01% 10179
2022
Q3
$0 Sell
45
-6
-12% -$59 ﹤0.01% 11154
2022
Q2
$1K Hold
51
﹤0.01% 10039
2022
Q1
$1K Hold
51
﹤0.01% 9976
2021
Q4
$0 Hold
51
﹤0.01% 10874
2021
Q3
$0 Buy
+51
New +$493 ﹤0.01% 10243

Other funds holding MACA

UBS Group's MACA Position: Q1 2023 in Review

UBS Group sold out of Moringa Acquisition Corp Class A Ordinary Shares (MACA) in Q1 2023, closing a stake of 45 shares — an estimated $453 sold.

UBS Group first reported a position in MACA in Q3 2021 and held it in 6 quarters. The position peaked at $1K in Q2 2022. 20 funds tracked by Wall St. Rank hold MACA as of Q1 2023.

  • UBS Group reported no remaining Moringa Acquisition Corp Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • UBS Group sold 45 Moringa Acquisition Corp Class A Ordinary Shares shares in Q1 2023, an estimated $453.
  • UBS Group first reported a position in Moringa Acquisition Corp Class A Ordinary Shares in Q3 2021 and held it in 6 quarters.
  • UBS Group's Moringa Acquisition Corp Class A Ordinary Shares position peaked at $1K in Q2 2022.
  • 20 funds tracked by Wall St. Rank held Moringa Acquisition Corp Class A Ordinary Shares as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.